Literature DB >> 3338030

Management of low-grade gliomas of the optic nerve and chiasm.

J C Flickinger1, C Torres, M Deutsch.   

Abstract

Thirty-six patients were evaluated between 1965 and 1983 for glioma of the optic nerves and/or chiasm. Median follow-up was 10.2 years. Pathologic verification was obtained in 32 patients. Tumor initially confined to the optic nerve recurred in one of five patients after complete resection. The actuarial survival for 25 patients irradiated for biopsy-proven glioma of the optic chiasm was 96%, 90%, and 90% at 5, 10, and 15 years, respectively, and the progression-free survival was 87% at 5, 10, and 15 years. Vision stabilized or improved in 86% of patients after radiotherapy. Patients irradiated to a dose greater than a NSD of 1385 ret had a significantly improved progression-free survival (P = 0.015). One serious complication occurred after a dose of 1533 ret. The recommended radiation dose for optic glioma is 45 to 50 Gy with 1.8 Gy fractions.

Entities:  

Mesh:

Year:  1988        PMID: 3338030     DOI: 10.1002/1097-0142(19880215)61:4<635::aid-cncr2820610403>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

Review 1.  Pediatric low-grade gliomas.

Authors:  Angela J Sievert; Michael J Fisher
Journal:  J Child Neurol       Date:  2009-11       Impact factor: 1.987

2.  Late sequela after treatment of childhood low-grade gliomas: a retrospective analysis of 69 long-term survivors treated between 1983 and 2003.

Authors:  Martin Benesch; Herwig Lackner; Petra Sovinz; Elisabeth Suppan; Wolfgang Schwinger; Hans-Georg Eder; Hans Jürgen Dornbusch; Andrea Moser; Karin Triebl-Roth; Christian Urban
Journal:  J Neurooncol       Date:  2006-04-25       Impact factor: 4.130

3.  Radiotherapy in pediatric pilocytic astrocytomas. A subgroup analysis within the prospective multicenter study HIT-LGG 1996 by the German Society of Pediatric Oncology and Hematology (GPOH).

Authors:  K Müller; A Gnekow; F Falkenstein; J Scheiderbauer; I Zwiener; T Pietsch; M Warmuth-Metz; J Voges; G Nikkhah; M Flentje; S E Combs; D Vordermark; M Kocher; R-D Kortmann
Journal:  Strahlenther Onkol       Date:  2013-07-07       Impact factor: 3.621

4.  Diencephalic tumors in children: a 30-year experience of a single institution.

Authors:  Nalan Yazici; Ali Varan; Nejat Akalan; Figen Söylemezoğlu; Faruk Zorlu; Tezer Kutluk; Canan Akyüz; Münevver Büyükpamukçu
Journal:  Childs Nerv Syst       Date:  2011-02-25       Impact factor: 1.475

5.  Multiple causes of cerebrovascular events in children with tumors of the parasellar region.

Authors:  M S Rudoltz; W F Regine; J W Langston; R A Sanford; E H Kovnar; L E Kun
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

6.  Our treatment philosophy of gliomas of the anterior visual pathways.

Authors:  V Benes; I Julisová; I Julis
Journal:  Childs Nerv Syst       Date:  1990-03       Impact factor: 1.475

Review 7.  An integrated approach to the treatment of chiasmatic-hypothalamic gliomas.

Authors:  M Garvey; R J Packer
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

8.  Analysis of 20 primarily surgically treated chiasmatic/hypothalamic pilocytic astrocytomas.

Authors:  J M Valdueza; F Lohmann; O Dammann; C Hagel; B Eckert; N Freckmann
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

Review 9.  Chemotherapeutic treatment of extensive optic pathway tumors in infants.

Authors:  C S Kretschmar; R M Linggood
Journal:  J Neurooncol       Date:  1991-06       Impact factor: 4.130

10.  Neurofibromatosis type 1 and sporadic optic gliomas.

Authors:  S Singhal; J M Birch; B Kerr; L Lashford; D G R Evans
Journal:  Arch Dis Child       Date:  2002-07       Impact factor: 3.791

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.